Koate Kit
NDC Package 76125-665-02
Package Information
Koate (antihemophilic factor (human)) kits is kOĀTE® is a human plasma-derived antihemophilic factor indicated for the control and prevention of bleeding episodes or in order to perform emergency and elective surgery in patients with hemophilia A (hereditary Factor VIII deficiency). This formulation utilizes a kit delivery system. Marketed by Kedrion Biopharma, Inc., this product is identified by NDC 76125-665 and is authorized under FDA application BLA101130.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76125 - Kedrion Biopharma, Inc.
- 76125-665 - Koate
- 76125-665-02 - 1 KIT in 1 CARTON * 5 mL in 1 VIAL, GLASS (76125-669-31) * 5 mL in 1 VIAL, GLASS (76297-002-02)
- 76125-665 - Koate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76125-665-02 identifies a specific commercial package of 1 kit in 1 carton * 5 ml in 1 vial, glass (76125-669-31) * 5 ml in 1 vial, glass (76297-002-02) of Koate, a plasma derivative labeled by Kedrion Biopharma, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This kit is formulated for intravenous use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kedrion Biopharma, Inc. on May 20, 1999. The current certification is valid through December 31, 2027.
How is this Kedrion Biopharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76125066502. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.